Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
Clinical trial NCT07509151 · RECRUITING
Trial details
- NCT number
- NCT07509151
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-05
- Primary completion
- 2031-08-29
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.